Top Markets
Coin of the day
ProQR Therapeutics N.V. ProQR Therapeutics N.V.

ProQR Therapeutics N.V.

PRQR
Classificação em ações #17697
ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to... ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ultevursen is also undergoing Phase II/III evaluation for the treatment of USH2A-mediated retinitis pigmentosa and Usher syndrome. Beyond its clinical programs, ProQR is actively developing its proprietary Axiomer RNA base-editing platform technology. Strategic collaborations are central to ProQR's strategy, evidenced by its licensing agreements with institutions such as Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center. Furthermore, a significant license and research partnership exists with Eli Lilly and Company, focused on the discovery, advancement, and commercialization of novel medicines for genetic conditions impacting the liver and nervous system. Established in 2012, ProQR Therapeutics N.V. maintains its corporate headquarters in Leiden, the Netherlands.
Preço da ação
$2.19
Valor de mercado
$230.27M
Variação (1 dia)
3.14%
Variação (1 ano)
-4.52%
País
NL
Negociar ProQR Therapeutics N.V. (PRQR)

Categoria

Histórico de preços das ações de ProQR Therapeutics N.V. (PRQR)
Preço de fecho mais alto: $2.15 em 2026-09-01

Preço de fecho mais baixo: $16.02 em 2014-09-01
Histórico de preços das ações da ProQR Therapeutics N.V. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -11.42%
2025 -28.54%
2024 50.91%
2023 1.70%
2022 -73.18%
2021 77.31%
2020 -55.12%
2019 -45.63%
2018 474.89%
2017 -32.99%
2016 -45.08%
2015 -56.15%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$556.43 38.76%
US
$1.05K 48.60%
NL
$152.82 531.75%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH